Tiziana Life Sciences Ltd
TLSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $37 | $28 | $30 | $47 |
| - Cash | $4 | $1 | $18 | $42 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $34 | $27 | $13 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$17 | -$17 | -$15 | -$26 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$18 | -$15 | -$23 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.22 | -0.34 | -0.3 | -0.48 |
| % Growth | 35.3% | -13.3% | 37.5% | – |
| Operating Cash Flow | -$1 | -$12 | -$16 | -$16 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | -$12 | -$16 | -$16 |